|
Rosadyn Focus Group Underway: 06-05-09
Vascular Health Specialists is pleased to announce that the Rosadyn Research Focus Group has been finalized, and testing is currently underway. The select focus group has received samples of the product for final pre-launch feedback and comments. Immediately following this evaluation phase, we will begin general distribution of Rosadyn.
We appreciate all the interest in this Focus Group and in the study. Due to overwhelming demand, we were not able to open up the group to all people, but will continue to update this site in regards to the progress of the tests, and details about the launch schedule. If you'd like to have the most up to date information about product launches, exclusive member offers, and other rosacea news, then please join our newsletter using the signup section at the bottom of the page.
|
New Focus Group Announced: 05-08-09
We are pleased to announce that the initial production run of Rosadyn will be fully manufactured by the end of next week. As the final stage of our pre-launch market analysis, Vascular Health Specialists is recruiting 50-100 rosacea sufferers to participate in a Rosadyn> focus group.
This focus group will be provided with a free one-month supply of Rosadyn in exchange for their survey feedback on a variety of topics, including current product usage, future product requests, etc.
If you would like to participate in this focus group and receive a free bottle of the newly manufactured Rosadyn, please go to www.rosadyn.com and enter your details there. Participants will be selected from this pool, with preference given to those who have already subscribed to the Rosadyn update newsletter.
|
Dr. Nase Announces Rosadyn - Advanced Oral Nutraceutical developed to address key manifestations of Facial Rosacea and Ocular Rosacea:
After more than 2 ½ years of research and development, Dr. Nase and Vascular Health Specialists, LLC are proud to announce the launch of this revolutionary new oral product, Rosadyn. Utilizing oral delivery of pharmaceutical-grade medicinal extracts, Rosadyn can treat deep facial blood vessels, damaged skin cells and cellular inflammation. This oral nutraceutical also treats ocular rosacea -- ocular surface inflammation, 'blood shot eyes', swelling of the eyelids and dry eye syndrome. This oral nutraceutical targets most of the key rosacea symptoms such as facial redness, flushing, inflammation, papules, swelling, ocular inflammation, and Hypothalamus overdrive (e.g. dilator nerve and hormone activity).
Rosadyn utilizes pharmaceutical-grade medicinal plant extracts and phospholipids to strengthen blood vessels, reduce new blood vessel growth, reduce chronic skin inflammation caused by inflammatory immune cells and break the dermal inflammatory cycle. These medicinal extracts also enhance the blood vessel repair mechanisms and strengthen the natural blood vessel defenses, a key benefit to all sufferers of rosacea.
Rosadyn will be available without a prescription, and is currently in the final stages of development with a launch date scheduled for May, 2009.
To be the first to be notified with launch date details, and get access to special launch pricing, signup for our newsletter below:
|
Newsletter Subscription
Signup here to receive product launch information, exclusive member offers, and other rosacea news:
|
12 | 13 |
22 | 24
|
|
|
